![]() |
RELATED RESOURCES |
SEC Filings:ENZNENZON PHARMACEUTICALS INC0.36672
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2016 | Form 8-K* | Current Report* | 11/14/2016 | 11/14/2016 |
Form 8-K* | Current Report* | 11/15/2016 | 11/14/2016 | |
Form 4 | Insider Transaction | 11/29/2016 | 11/28/2016 | |
Form SC 13D/A | Acquistion of beneficial ownership | 11/29/2016 | N/A | |
Form 8-K* | Current Report* | 12/08/2016 | 12/08/2016 | |
Form SC 13D/A | Acquistion of beneficial ownership | 12/08/2016 | N/A | |
2017 | Form SC 13G/A | Beneficial Ownership Statement | 02/14/2017 | N/A |
2016 | Form 10-K* | Annual Report* | 03/24/2017 | 12/31/2016 |
Form 10-K/A* | Annual Report* | 04/28/2017 | 12/31/2016 | |
2017 | Form 10-Q* | Quarterly Report* | 05/11/2017 | 03/31/2017 |
Form DEF 14A | Definitive Proxy Statements | 05/12/2017 | 06/28/2017 | |
Form DEFA14A | Definitive Proxy Statements | 05/12/2017 | N/A | |
Form SC 13G | Beneficial Ownership Statement | 05/24/2017 | N/A | |
Form 8-K* | Current Report* | 06/30/2017 | 06/26/2017 | |
Form 10-Q* | Quarterly Report* | 08/10/2017 | 06/30/2017 |